KVUE

Handel nachbörslich: 22.70 0.03 +0.13%

Kenvue Inc (KVUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt KVUE? Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Kenvue Inc Stock (KVUE) Company Profile

Consumer Defensive (250)

908-874-1200

1 KENVUE WAY, SUMMIT

Nächster Verdiensttermin

Neueste SEC-Einreichungen

KVUE's Discussions on Twitter

Vergleichen Sie KVUE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KVUE Kenvue Inc	22.67	41.07B	15.30B	1.06B	1.45B	0.55
PG Procter Gamble Co	158.32	357.96B	83.93B	15.50B	15.03B	6.30
UL Unilever Plc Adr	60.34	147.74B	65.10B	6.16B	0	2.4569
CL Colgate Palmolive Co	88.70	71.44B	19.95B	2.90B	3.47B	3.54
KMB Kimberly Clark Corp	128.89	42.06B	19.75B	2.47B	2.39B	7.34

Kenvue Inc Stock (KVUE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-10	Eingeleitet	Redburn Atlantic	Neutral
2025-03-24	Eingeleitet	Evercore ISI	In-line
2025-01-06	Hochstufung	Piper Sandler	Neutral → Overweight
2024-12-12	Herabstufung	Deutsche Bank	Buy → Hold
2024-09-24	Eingeleitet	Jefferies	Buy
2024-09-24	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-05-28	Fortgesetzt	Citigroup	Neutral
2024-04-11	Eingeleitet	Bernstein	Underperform
2024-04-03	Eingeleitet	William Blair	Mkt Perform
2024-03-01	Fortgesetzt	Goldman	Neutral
2023-11-17	Eingeleitet	Piper Sandler	Neutral
2023-09-11	Hochstufung	Deutsche Bank	Hold → Buy
2023-09-07	Eingeleitet	Canaccord Genuity	Buy
2023-09-06	Eingeleitet	Argus	Hold
2023-08-24	Hochstufung	Goldman	Neutral → Buy
2023-07-25	Eingeleitet	Edward Jones	Buy
2023-06-01	Eingeleitet	HSBC Securities	Hold
2023-05-30	Eingeleitet	BofA Securities	Buy
2023-05-30	Eingeleitet	Citigroup	Neutral
2023-05-30	Eingeleitet	Deutsche Bank	Hold
2023-05-30	Eingeleitet	Exane BNP Paribas	Neutral
2023-05-30	Eingeleitet	Goldman	Neutral
2023-05-30	Eingeleitet	JP Morgan	Overweight
2023-05-30	Eingeleitet	RBC Capital Mkts	Outperform
2023-05-30	Eingeleitet	UBS	Neutral

Alle ansehen

Kenvue Inc Aktie (KVUE) Neueste Nachrichten

Finanzdaten der Kenvue Inc-Aktie (KVUE)

Kenvue Inc (KVUE)

Kenvue Inc Stock (KVUE) Company Profile

Vergleichen Sie KVUE mit anderen Aktien

Kenvue Inc Stock (KVUE) Upgrades & Downgrades

Kenvue Inc Aktie (KVUE) Neueste Nachrichten

Beacon Investment Advisory Services Inc. Boosts Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue Inc. Stock Analysis and ForecastTremendous financial leverage - jammulinksnews.com

Wesleyan Assurance Society Sells 23,687 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat

HighPoint Advisor Group LLC Sells 25,455 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue: Tylenol Can't Ease The Pain, Pricey Stock, Dividend In Vain - Seeking Alpha

Is Kenvue (KVUE) a Halal Dividend Stock Worth Adding to Your Portfolio? - MSN

What drives Kenvue Inc. stock priceSuperior return velocity - Autocar Professional

Rep. C. Scott Franklin Sells Off Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue's Dividend Performance and Growth Outlook Amidst Tariffs and Currency Fluctuations - AInvest

Kenvue Target of Unusually Large Options Trading (NYSE:KVUE) - MarketBeat

What analysts say about Kenvue Inc. stockGame-changing returns - Autocar Professional

SHAREHOLDER ALERT: Levi & Korsinsky Reminds Kenvue Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2023KVUE - ACCESS Newswire

Kenvue Inc. (NYSE:KVUE) Position Reduced by Crestwood Advisors Group LLC - MarketBeat

Is Kenvue Inc.'s (NYSE:KVUE) Recent Price Movement Underpinned By Its Weak Fundamentals? - 富途牛牛

Kenvue collaborates with API to launch India’s first cough clinics to advance symptom science in respiratory primary care - Pharmabiz.com

Diversify Advisory Services LLC Makes New $304,000 Investment in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue Inc. (NYSE:KVUE) Shares Acquired by Larson Financial Group LLC - MarketBeat

UBS Group Has Lowered Expectations for Kenvue (NYSE:KVUE) Stock Price - MarketBeat

Kenvue Announces CEO Transition - supermarketnews.co.nz

(KVUE) Investment Report - news.stocktradersdaily.com

Richard C. Young & CO. LTD. Raises Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Wealthfront Advisers LLC Grows Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Is Kenvue Inc. a good long term investmentConsistently high returns - jammulinksnews.com

Legacy Capital Wealth Partners LLC Reduces Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue Inc. (NYSE:KVUE) Shares Sold by Cooke & Bieler LP - MarketBeat

Citigroup Cuts Kenvue (NYSE:KVUE) Price Target to $22.00 - MarketBeat

Mutual of America Capital Management LLC Has $7.05 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue Inc. (NYSE:KVUE) is Equity Investment Corp's 8th Largest Position - MarketBeat

Kenvue's Q2 2025 Earnings: What to Expect - MSN

Kenvue Inc. shares fall 1.14% after-hours as FTC approves Synopsys-Ansys divestiture. - AInvest

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing - MSN

Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie - Benzinga

Jim Cramer is Confident “Someone Will Want Some of Kenvue” - MSN

Tylenol maker Kenvue fires CEO amid board's strategic review - MSN

Bank of America Cuts Kenvue (NYSE:KVUE) Price Target to $25.00 - MarketBeat

Barclays Cuts Kenvue (NYSE:KVUE) Price Target to $22.00 - MarketBeat

Kenvue Inc. (NYSE:KVUE) Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat

New York State Common Retirement Fund Reduces Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Kenvue (NYSE:KVUE) Updates Q2 2025 Earnings Guidance - MarketBeat

Kenvue outlook revised to negative by S&P amid strategic review - Investing.com India

Kenvue (NYSE:KVUE) Shares Gap UpHere's Why - MarketBeat

Kenvue drama shows not all spin-offs are created equal - Financial Times

Deutsche Bank Sticks to Its Hold Rating for Kenvue, Inc. (KVUE) - The Globe and Mail

UBS Adjusts Kenvue Price Target to $23 From $25, Maintains Neutral Rating - MarketScreener

Easterly Investment Partners LLC Has $1.93 Million Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Cullen Frost Bankers Inc. Acquires 12,516 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat

The Escalator: Johnson & Johnson MedTech, Jazz Pharmaceuticals, Kenvue and more - Medical Marketing and Media

Finanzdaten der Kenvue Inc-Aktie (KVUE)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie KVUE